Most Popular Stories
- Ben Venue can't say when crucial cancer drug will be available
- Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds
- Ben Venue's idled plant triggers 'dire' leukemia-drug shortage
- Novartis dealt another setback to broader Menveo use
- The best of times, the worst of times?
- Curcumin, in Indian curry spice, may beat down prostate tumors
- Pioneering stem cell therapy mends damaged heart tissue in patients
- GSK studies Chinese remedies to discover new drugs
- Chelsea shares nosedive on FDA's questions about key drug
- DNA sequencing exposes new uses for Pfizer targeted cancer drugs
- Preclinical study triggers 'massive response' from desperate Alzheimer's patients
Webinars
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to MarketJoin us for a one-hour overview of the regulated clinical trials process used to bring a n
Featured Jobs
-
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ -
Director Marketing Communications
Bailey Search & Associates - Boston, MA -
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US
Events
- BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida - CALBIO2012: Driven By Patients - Marriott Marquis
March 8-9 — San Francisco, CA - Pharmaceutical Strategic Outlook
April 11-13, 2012 - Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- The Voice of the Site Coordinator
- Best Practices: ERP Vendor Reference-Checking
- Niche Tourism Beginning and digital marketing : Beginning of the future?
- The Cutting Edge of Chemistry
- The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses
- Displacement Chromatography Comes of Age - An indispencable tool for the purification of biomacromolecules
Achaogen CEO Kevin Judice
